DX-890 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
299嚢胞性線維症4

299. 嚢胞性線維症


臨床試験数 : 1,695 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002341-12-BE
(EUCTR)
05/08/200525/08/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy
2EUCTR2004-002341-12-GB
(EUCTR)
15/04/200510/02/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90Phase 2Belgium;Germany;Italy;United Kingdom
3EUCTR2004-002341-12-DE
(EUCTR)
14/02/200524/09/2004Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy
4EUCTR2004-002341-12-IT
(EUCTR)
12/01/200516/03/2005Multicenter, 8-week, Randomised,Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised,Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients cystic fibrosis
MedDRA version: 6.1;Level: PT;Classification code 10011762
Product Name: DEPELESTAT
Product Code: DX-890
INN or Proposed INN: Other respiratory system products
Product Name: DEPELESTAT
Product Code: DX-890
INN or Proposed INN: Other respiratory system products
DEBIOPHARM S.A.NULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy